Effects of chronic obesity and weight loss on plasma ghrelin and leptin concentrations in dogs.
The objective of this study was to evaluate, in dogs, the effects of obesity and weight loss on plasma total ghrelin and leptin concentrations. Twenty-four Beagle dogs, 12 control lean and 12 obese dogs of both genders and aged between 1 and 9 years, were used for the experiments. Mean body weight was 12.7+/-0.7 kg for the lean group and 21.9+/-0.8 kg for the obese group. The trial was divided into three phases. During phase 1, all 24 Beagle dogs were fed a maintenance diet. During phase 2, the obese dogs were submitted to a weight loss protocol with a high protein-low energy diet. The weight loss protocol ended once dogs reached optimal body weight. During phase 3, the dogs that were submitted to the weight loss protocol were maintained at their optimal body weight for 6 months. Plasma total ghrelin, leptin, insulin and glucose concentrations were measured to evaluate the effects of obesity and weight loss on these parameters in dogs. Body weight, body condition score, thoracic and pelvic perimeters, and ingested food amounts were also recorded during the study. Obese dogs demonstrated a significant decrease in plasma ghrelin and a significant increase in plasma leptin and insulin concentrations when compared with control dogs. During weight loss, significant increases in plasma total ghrelin and glucose and significant decreases in plasma leptin and insulin were observed. The increase in plasma ghrelin concentrations seemed to be transient. Body weight and the morphometric parameters correlated positively with leptin concentrations and negatively with total ghrelin concentrations. These results suggest that ghrelin and leptin could play a role in dogs in the adaptation to a positive or negative energy balance, as observed in humans.
Jeusette
Isabelle C
IC
Affinity-Petcare, 08174, Barcelona, Spain.
Detilleux
Johanne
J
Shibata
Haruki
H
Saito
Masayuki
M
Honjoh
Tsutomu
T
Delobel
Agathe
A
Istasse
Louis
L
Diez
Marianne
M
D000818:Animals; D001786:Blood Glucose; D004283:Dog Diseases / Q000097:blood* / Q000503:physiopathology; D004285:Dogs; D005260:Female; D054439:Ghrelin; D007328:Insulin / Q000097:blood; D020738:Leptin / Q000097:blood*; D008297:Male; D009765:Obesity / Q000097:blood / Q000503:physiopathology / Q000662:veterinary*; D036361:Peptide Hormones / Q000097:blood*; D015431:Weight Loss / Q000502:physiology
D001786:Blood Glucose; D054439:Ghrelin; D007328:Insulin; D020738:Leptin; D036361:Peptide Hormones